Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
1 other identifier
interventional
768
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness and implementation of a pharmacist-delivered MTM (medication therapy management) approach, called QuitAid, to quitting cigarette smoking in rural Appalachia. The main questions it aims to answer are:
- Is QuitAid, alone or combined with other quitting tobacco treatments, effective?
- What makes QuitAid easy or hard to carry out? Is it cost effective? Is it easy to maintain? Treatment: All participants will be given at least 4 weeks of the nicotine patch. Some participants will be randomized (like the flip of a coin) to receive additional treatments (listed below). These groups will be compared to each other to see which combination works best to help them quit smoking.
- Smokefree TXT - a texting program that helps people quit smoking
- Tobacco quitline - 4 phone sessions to help people quit smoking
- 8 weeks of NRT (nicotine replacement therapy in the form of nicotine patches or nicotine patches and lozenge) medication instead of 4 weeks
- QuitAid - An MTM program given by the patient's pharmacist. This is a quitting smoking coaching program
- Nicotine patch AND nicotine lozenge instead of just nicotine patches
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2022
CompletedFirst Posted
Study publicly available on registry
December 21, 2022
CompletedStudy Start
First participant enrolled
March 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
April 20, 2026
April 1, 2026
3.2 years
December 13, 2022
April 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Tobacco Abstinence
The primary outcome is biochemically verified point prevalence (verified through a CO test via Smokerlyzer at endpoint of participation in trial) abstinence defined as no smoking (even a puff) within the past 7 days.
6 months
Secondary Outcomes (3)
Self-Reported Tobacco Abstinence
1, 2, and 3 months
Adherence to assigned treatment components
1, 2, and 3 months
Quit Attempts
1, 2, and 3 months
Study Arms (32)
QuitAid, 4 weeks, Patch + Lozenge
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist and 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and the nicotine lozenge.
QuitAid, 8 weeks, Patch + Lozenge
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist and 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and the nicotine lozenge.
QuitAid, 4 weeks, Patch + Lozenge, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and the nicotine lozenge, and a Quitline intervention
QuitAid, 8 weeks, Patch + Lozenge, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and the nicotine lozenge, and a Quitline intervention
QuitAid, 4 weeks, Patch
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist and 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch.
QuitAid, 8 weeks, Patch
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist and 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch.
QuitAid, 8 weeks, Patch, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a Quitline intervention
QuitAid, 4 weeks, Patch, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a Quitline intervention
QuitAid, 4 weeks, Patch, SmokeFree Txt
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a texting intervention to help quit smoking.
QuitAid, 8 weeks, Patch, SmokeFree Txt
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a texting intervention to help quit smoking.
QuitAid, 8 weeks, Patch + Lozenge, SmokeFree Txt
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, and a texting intervention to help quit smoking.
QuitAid, 4 weeks, Patch + Lozenge, SmokeFree Txt
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, and a texting intervention to help quit smoking.
QuitAid, 8 weeks, Patch + Lozenge, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, a texting intervention to help quit smoking, and a Quitline Intervention.
QuitAid, 8 weeks, Patch, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, a texting intervention to help quit smoking, and a Quitline Intervention.
QuitAid, 4 weeks, Patch + Lozenge, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, a texting intervention to help quit smoking, and a Quitline Intervention.
QuitAid, 4 weeks, Patch, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive QuitAid, a medication therapy management delivered by their pharmacist, 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, a texting intervention to help quit smoking, and a Quitline Intervention.
8 weeks, Patch + Lozenge, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, a texting intervention to help quit smoking, and a Quitline Intervention.
8 weeks, Patch, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, a texting intervention to help quit smoking, and a Quitline Intervention.
4 weeks, Patch + Lozenge, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, a texting intervention to help quit smoking, and a Quitline Intervention.
4 weeks, Patch, SmokeFree Txt, QuitLine
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, a texting intervention to help quit smoking, and a Quitline Intervention.
8 weeks, Patch + Lozenge, QuitLine
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, and a Quitline Intervention.
8 weeks, Patch, QuitLine
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a Quitline Intervention.
4 weeks, Patch + Lozenge, QuitLine
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge, and a Quitline Intervention.
4 weeks, Patch, QuitLine
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch, and a Quitline Intervention.
8 weeks, Patch + Lozenge, SmokeFree Txt
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge and a texting intervention to help quit smoking.
8 weeks, Patch, SmokeFree Txt
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and a texting intervention to help quit smoking.
4 weeks, Patch + Lozenge, SmokeFree Txt
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge and a texting intervention to help quit smoking.
4 weeks, Patch, SmokeFree Txt
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and a texting intervention to help quit smoking.
8 weeks, Patch + Lozenge
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge.
8 weeks, Patch
EXPERIMENTALSmoking participants receive 8 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch.
4 weeks, Patch + Lozenge
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch and lozenge.
4 weeks, Patch
EXPERIMENTALSmoking participants receive 4 weeks Nicotine Replacement Therapy (NRT) in the form of the nicotine patch.
Interventions
All participants will receive at least 4 weeks of the NRT Patch. Some will be randomized to receive 4 weeks of lozenge in addition to the NRT Patch. NRT temporarily replaces nicotine from tobacco to reduce motivation to consume tobacco and nicotine withdrawal symptoms.
All participants will receive at least 4 weeks of the NRT Patch. Some will also be randomized to receive an additional 4 weeks of the NRT Patch
All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive the QuitAid intervention, based on a medication adherence intervention, addresses perceptions (e.g., motivation, self-efficacy, beliefs) and practicalities of using NRT (e.g., monitoring NRT use, establishing a reminder system). QuitAid includes 1 in-person session and 5 follow-up telephonic sessions with the participant's local pharmacist/technician.
All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive the SmokefreeTXT is a text-messaging program offered through the National Cancer Institute's Smokefree.gov initiative, which sends pre-programmed messages timed around a quit date. Participants will receive 3-5 messages a day for 7 weeks. The first week of messages focus on preparation and the remaining 6 weeks of messages focus on post-cessation strategies (e.g., relapse prevention), all timed relative to the quit date set at enrollment.
All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive a 4-session proactive tobacco quitline, with each session lasting 20-30 minutes and occurring on days 7, 14, 21 and 28.The quitline intervention incorporates 3 phases: (1) preparing to quit, (2) quitting process, and (3) relapse prevention.
All participants will receive at least 4 weeks of the NRT Patch.
All participants will receive at least 4 weeks of the NRT Patch. Some will be randomized to receive 8 weeks of lozenge in addition to the NRT Patch. NRT temporarily replaces nicotine from tobacco to reduce motivation to consume tobacco and nicotine withdrawal symptoms.
Eligibility Criteria
You may qualify if:
- must be 18 years of age and older
- must be able to read, speak, and understand English
- must report smoking at least 5 cigarettes per day for the past 6 months (regardless of non-cigarette tobacco product use)
- must be willing to set a quit date within the next 30 days
- must own a cell phone
- must be willing and able to use NRT in the form of patch or lozenge
- Not be pregnant or planning to be pregnant in the next 6 months.
You may not qualify if:
- are pregnant women (self-reported), breastfeeding, planning to become pregnant during the next 6 months
- have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22904, United States
Related Publications (1)
Fahey MC, Krukowski RA, Anderson RT, Cohn WF, Porter KJ, Reid T, Wiseman KP, You W, Wood CH, Rucker TW, Little MA. Reaching adults who smoke cigarettes in rural Appalachia: Rationale, design & analysis plan for a mixed-methods study disseminating pharmacy-delivered cessation treatment. Contemp Clin Trials. 2023 Nov;134:107335. doi: 10.1016/j.cct.2023.107335. Epub 2023 Sep 18.
PMID: 37730197DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Little, PhD, MPH
University of Virginia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 13, 2022
First Posted
December 21, 2022
Study Start
March 6, 2024
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
March 1, 2028
Last Updated
April 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
No plans to share data at the individual level